| 0 |
PRE-ENGRAFTMENT IMMUNE REACTION |
65 |
0.8125 |
| 1 |
ADENOVIRUS REACTIVATION |
105 |
0.7292 |
| 2 |
MENINGOMYELITIS HERPES |
20 |
0.6250 |
| 3 |
CYTOKINE INCREASED |
69 |
0.5111 |
| 4 |
CHIMERISM |
40 |
0.4494 |
| 5 |
PROTOTHECOSIS |
41 |
0.4362 |
| 6 |
VIRAL HAEMORRHAGIC CYSTITIS |
300 |
0.4213 |
| 7 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
1164 |
0.4207 |
| 8 |
CYSTITIS VIRAL |
161 |
0.4204 |
| 9 |
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE |
584 |
0.4133 |
| 10 |
MALIGNANT GENITOURINARY TRACT NEOPLASM |
27 |
0.4030 |
| 11 |
JUVENILE CHRONIC MYELOMONOCYTIC LEUKAEMIA |
20 |
0.3922 |
| 12 |
ENGRAFTMENT SYNDROME |
208 |
0.3519 |
| 13 |
IDIOPATHIC PNEUMONIA SYNDROME |
104 |
0.3490 |
| 14 |
HUMAN HERPESVIRUS 6 ENCEPHALITIS |
98 |
0.3451 |
| 15 |
VIRURIA |
37 |
0.3426 |
| 16 |
CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT |
237 |
0.3400 |
| 17 |
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME |
20 |
0.3390 |
| 18 |
ACUTE GRAFT VERSUS HOST DISEASE |
1538 |
0.3357 |
| 19 |
ENCEPHALITIS CYTOMEGALOVIRUS |
147 |
0.3356 |
| 20 |
ACUTE GRAFT VERSUS HOST DISEASE IN LIVER |
237 |
0.3296 |
| 21 |
BONE MARROW TRANSPLANT REJECTION |
72 |
0.3273 |
| 22 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
691 |
0.3244 |
| 23 |
CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE |
61 |
0.3211 |
| 24 |
CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN |
295 |
0.3186 |
| 25 |
GRAFT VERSUS HOST DISEASE IN SKIN |
695 |
0.3152 |
| 26 |
AUTOIMMUNE PANCYTOPENIA |
27 |
0.2967 |
| 27 |
CORD BLOOD TRANSPLANT THERAPY |
25 |
0.2941 |
| 28 |
ADENOVIRAL HEPATITIS |
69 |
0.2936 |
| 29 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
1292 |
0.2922 |
| 30 |
DISSEMINATED TOXOPLASMOSIS |
35 |
0.2917 |
| 31 |
ADENOVIRUS INFECTION |
840 |
0.2894 |
| 32 |
RETINITIS VIRAL |
35 |
0.2893 |
| 33 |
GASTROENTERITIS ASTROVIRAL |
23 |
0.2875 |
| 34 |
CHRONIC GRAFT VERSUS HOST DISEASE IN EYE |
58 |
0.2857 |
| 35 |
BLOOD STEM CELL TRANSPLANT FAILURE |
60 |
0.2791 |
| 36 |
ENGRAFT FAILURE |
80 |
0.2787 |
| 37 |
CHRONIC LYMPHOCYTIC LEUKAEMIA TRANSFORMATION |
58 |
0.2775 |
| 38 |
IMMUNE EFFECTOR CELL-ASSOCIATED HAEMATOTOXICITY |
48 |
0.2759 |
| 39 |
BRONCHIOLITIS OBLITERANS SYNDROME |
47 |
0.2686 |
| 40 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
346 |
0.2627 |
| 41 |
CHRONIC GRAFT VERSUS HOST DISEASE |
942 |
0.2607 |
| 42 |
CHRONIC GRAFT VERSUS HOST DISEASE ORAL |
61 |
0.2490 |
| 43 |
CHRONIC GRAFT VERSUS HOST DISEASE IN LUNG |
43 |
0.2486 |
| 44 |
STENOTROPHOMONAS SEPSIS |
30 |
0.2479 |
| 45 |
ADENOVIRAL HAEMORRHAGIC CYSTITIS |
51 |
0.2452 |
| 46 |
HUMAN HERPESVIRUS 6 INFECTION |
460 |
0.2431 |
| 47 |
PARAINFLUENZA VIRUS INFECTION |
25 |
0.2427 |
| 48 |
EPSTEIN-BARR VIRAEMIA |
268 |
0.2417 |
| 49 |
GASTROENTERITIS ADENOVIRUS |
37 |
0.2357 |
| 50 |
CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER |
85 |
0.2335 |
| 51 |
GRAFT VERSUS HOST DISEASE IN EYE |
51 |
0.2208 |
| 52 |
LEUKOERYTHROBLASTOSIS |
22 |
0.2200 |
| 53 |
OUT OF SPECIFICATION TEST RESULTS |
22 |
0.2200 |
| 54 |
BK POLYOMAVIRUS TEST POSITIVE |
21 |
0.2188 |
| 55 |
BK VIRUS INFECTION |
725 |
0.2148 |
| 56 |
CHRONIC LYMPHOCYTIC LEUKAEMIA REFRACTORY |
20 |
0.2128 |
| 57 |
HUMAN HERPESVIRUS 6 INFECTION REACTIVATION |
71 |
0.2023 |
| 58 |
MENINGITIS TUBERCULOUS |
113 |
0.2021 |
| 59 |
ACUTE MYELOID LEUKAEMIA RECURRENT |
430 |
0.2001 |
| 60 |
GRAFT VERSUS HOST DISEASE IN LIVER |
143 |
0.1997 |
| 61 |
GEOTRICHUM INFECTION |
42 |
0.1991 |
| 62 |
MICROSPORIDIA INFECTION |
69 |
0.1966 |
| 63 |
GRAFT VERSUS HOST DISEASE IN INTESTINE |
25 |
0.1923 |
| 64 |
B-CELL APLASIA |
49 |
0.1899 |
| 65 |
HERPES SIMPLEX PNEUMONIA |
24 |
0.1890 |
| 66 |
FUSARIUM INFECTION |
128 |
0.1829 |
| 67 |
PNEUMONIA ADENOVIRAL |
35 |
0.1768 |
| 68 |
BLOOD STEM CELL HARVEST FAILURE |
26 |
0.1757 |
| 69 |
VENOOCCLUSIVE LIVER DISEASE |
865 |
0.1750 |
| 70 |
GRAFT VERSUS HOST DISEASE |
1248 |
0.1734 |
| 71 |
CONGENITAL APLASIA |
53 |
0.1704 |
| 72 |
VENOOCCLUSIVE DISEASE |
426 |
0.1700 |
| 73 |
CYSTITIS HAEMORRHAGIC |
678 |
0.1680 |
| 74 |
ALLOGENIC STEM CELL TRANSPLANTATION |
26 |
0.1646 |
| 75 |
CAR T-CELL-RELATED ENCEPHALOPATHY SYNDROME |
20 |
0.1613 |
| 76 |
TRANSPLANT FAILURE |
394 |
0.1606 |
| 77 |
CYTOKINE RELEASE SYNDROME |
3015 |
0.1501 |
| 78 |
AUTOIMMUNE NEUTROPENIA |
43 |
0.1488 |
| 79 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
854 |
0.1440 |
| 80 |
ENCEPHALITIS VIRAL |
173 |
0.1420 |
| 81 |
ACUTE MYELOID LEUKAEMIA REFRACTORY |
24 |
0.1395 |
| 82 |
HUMAN POLYOMAVIRUS INFECTION |
74 |
0.1394 |
| 83 |
5Q MINUS SYNDROME |
22 |
0.1375 |
| 84 |
UPPER RESPIRATORY FUNGAL INFECTION |
26 |
0.1368 |
| 85 |
CEREBRAL TOXOPLASMOSIS |
126 |
0.1349 |
| 86 |
CYTOMEGALOVIRUS VIRAEMIA |
586 |
0.1316 |
| 87 |
SYSTEMIC MYCOSIS |
152 |
0.1301 |
| 88 |
VIRAEMIA |
178 |
0.1284 |
| 89 |
DISSEMINATED MUCORMYCOSIS |
50 |
0.1269 |
| 90 |
HERPES ZOSTER INFECTION NEUROLOGICAL |
20 |
0.1258 |
| 91 |
HYPOGAMMAGLOBULINAEMIA |
810 |
0.1232 |
| 92 |
ENTEROCOLITIS VIRAL |
37 |
0.1217 |
| 93 |
ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT |
301 |
0.1165 |
| 94 |
TOXOPLASMOSIS |
124 |
0.1148 |
| 95 |
LEUKAEMIA RECURRENT |
193 |
0.1141 |
| 96 |
INFECTION REACTIVATION |
130 |
0.1135 |
| 97 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
575 |
0.1129 |
| 98 |
JC VIRUS INFECTION |
179 |
0.1119 |
| 99 |
EPSTEIN-BARR VIRUS INFECTION |
682 |
0.1091 |
| 100 |
GRAFT VERSUS HOST DISEASE IN LUNG |
52 |
0.1088 |
| 101 |
SHORT STATURE |
28 |
0.1069 |
| 102 |
ENTEROCOCCAL BACTERAEMIA |
113 |
0.1066 |
| 103 |
SPINAL INSTABILITY |
27 |
0.1063 |
| 104 |
MANTLE CELL LYMPHOMA RECURRENT |
46 |
0.1057 |
| 105 |
MINIMAL RESIDUAL DISEASE |
50 |
0.1035 |
| 106 |
CYTOMEGALOVIRUS INFECTION |
1692 |
0.1017 |
| 107 |
PNEUMONIA CYTOMEGALOVIRAL |
197 |
0.1013 |
| 108 |
POLYOMAVIRUS VIRAEMIA |
106 |
0.0998 |
| 109 |
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER |
170 |
0.0961 |
| 110 |
KLEBSIELLA SEPSIS |
108 |
0.0958 |
| 111 |
HERPES ZOSTER REACTIVATION |
25 |
0.0954 |
| 112 |
MENINGOENCEPHALITIS HERPETIC |
41 |
0.0915 |
| 113 |
GASTROENTERITIS ROTAVIRUS |
28 |
0.0909 |
| 114 |
GRAFT COMPLICATION |
53 |
0.0903 |
| 115 |
ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION |
82 |
0.0886 |
| 116 |
CYTOMEGALOVIRUS CHORIORETINITIS |
173 |
0.0886 |
| 117 |
B-CELL TYPE ACUTE LEUKAEMIA |
65 |
0.0886 |
| 118 |
COMPLICATIONS OF BONE MARROW TRANSPLANT |
31 |
0.0859 |
| 119 |
ENTEROBACTER BACTERAEMIA |
26 |
0.0858 |
| 120 |
CHLOROMA |
36 |
0.0853 |
| 121 |
CEREBRAL ASPERGILLOSIS |
52 |
0.0846 |
| 122 |
OBLITERATIVE BRONCHIOLITIS |
111 |
0.0845 |
| 123 |
PARVOVIRUS INFECTION |
33 |
0.0817 |
| 124 |
VIRAL DIARRHOEA |
28 |
0.0814 |
| 125 |
CRYPTOSPORIDIOSIS INFECTION |
42 |
0.0800 |
| 126 |
STENOTROPHOMONAS INFECTION |
108 |
0.0796 |
| 127 |
PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL |
67 |
0.0795 |
| 128 |
LEUKAEMIC INFILTRATION EXTRAMEDULLARY |
20 |
0.0784 |
| 129 |
MUCOSAL TOXICITY |
21 |
0.0775 |
| 130 |
PARAINFLUENZAE VIRUS INFECTION |
118 |
0.0775 |
| 131 |
CYTOMEGALOVIRUS HEPATITIS |
27 |
0.0763 |
| 132 |
THROMBOTIC MICROANGIOPATHY |
741 |
0.0760 |
| 133 |
ENTEROCOCCAL SEPSIS |
61 |
0.0753 |
| 134 |
SCEDOSPORIUM INFECTION |
53 |
0.0751 |
| 135 |
RHINOCEREBRAL MUCORMYCOSIS |
26 |
0.0749 |
| 136 |
KLEBSIELLA BACTERAEMIA |
71 |
0.0747 |
| 137 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
255 |
0.0743 |
| 138 |
VARICELLA ZOSTER VIRUS INFECTION |
153 |
0.0737 |
| 139 |
REFRACTORY ANAEMIA WITH AN EXCESS OF BLASTS |
23 |
0.0735 |
| 140 |
DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV |
24 |
0.0732 |
| 141 |
ENTEROBACTER SEPSIS |
27 |
0.0730 |
| 142 |
ALTERNARIA INFECTION |
27 |
0.0726 |
| 143 |
CITROBACTER INFECTION |
31 |
0.0723 |
| 144 |
MYELOID LEUKAEMIA |
36 |
0.0719 |
| 145 |
PREMATURE MENOPAUSE |
66 |
0.0714 |
| 146 |
MALIGNANT TRANSFORMATION |
32 |
0.0713 |
| 147 |
UREAPLASMA INFECTION |
29 |
0.0711 |
| 148 |
DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION |
33 |
0.0707 |
| 149 |
CYTOMEGALOVIRUS TEST POSITIVE |
124 |
0.0695 |
| 150 |
FUNGAEMIA |
109 |
0.0692 |
| 151 |
BACTERIAL SEPSIS |
225 |
0.0690 |
| 152 |
ENCEPHALITIS HERPES |
34 |
0.0688 |
| 153 |
SYSTEMIC CANDIDA |
172 |
0.0684 |
| 154 |
CORONA VIRUS INFECTION |
29 |
0.0674 |
| 155 |
BRONCHOPULMONARY ASPERGILLOSIS |
518 |
0.0667 |
| 156 |
MYELODYSPLASTIC SYNDROME |
963 |
0.0665 |
| 157 |
CAMPYLOBACTER INFECTION |
55 |
0.0662 |
| 158 |
TOXIC LEUKOENCEPHALOPATHY |
48 |
0.0661 |
| 159 |
HERPES SIMPLEX REACTIVATION |
25 |
0.0656 |
| 160 |
ASPERGILLUS TEST POSITIVE |
20 |
0.0649 |
| 161 |
PULMONARY MUCORMYCOSIS |
34 |
0.0644 |
| 162 |
GROWTH FAILURE |
22 |
0.0640 |
| 163 |
PARVOVIRUS B19 INFECTION |
57 |
0.0637 |
| 164 |
CANDIDA SEPSIS |
57 |
0.0635 |
| 165 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
524 |
0.0635 |
| 166 |
MUCORMYCOSIS |
165 |
0.0634 |
| 167 |
BLADDER HYPERTROPHY |
28 |
0.0633 |
| 168 |
PSEUDOMONAL SEPSIS |
111 |
0.0633 |
| 169 |
FUNGAL SEPSIS |
52 |
0.0626 |
| 170 |
STEM CELL TRANSPLANT |
155 |
0.0620 |
| 171 |
TRANSPLANTATION COMPLICATION |
26 |
0.0619 |
| 172 |
CYTOMEGALOVIRUS ENTERITIS |
22 |
0.0618 |
| 173 |
PNEUMONIA FUNGAL |
244 |
0.0618 |
| 174 |
CENTRAL NERVOUS SYSTEM LEUKAEMIA |
24 |
0.0611 |
| 175 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
447 |
0.0595 |
| 176 |
B-CELL LYMPHOMA RECURRENT |
32 |
0.0589 |
| 177 |
STREPTOCOCCAL BACTERAEMIA |
64 |
0.0588 |
| 178 |
POLYSEROSITIS |
25 |
0.0587 |
| 179 |
APLASIA |
115 |
0.0587 |
| 180 |
ASPERGILLUS INFECTION |
385 |
0.0586 |
| 181 |
APLASTIC ANAEMIA |
304 |
0.0581 |
| 182 |
ANAEMIA HAEMOLYTIC AUTOIMMUNE |
46 |
0.0556 |
| 183 |
MUCOSAL INFLAMMATION |
1439 |
0.0549 |
| 184 |
SINUSITIS FUNGAL |
44 |
0.0549 |
| 185 |
DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT |
119 |
0.0539 |
| 186 |
AUTOIMMUNE THROMBOCYTOPENIA |
23 |
0.0531 |
| 187 |
INTERLEUKIN LEVEL INCREASED |
29 |
0.0525 |
| 188 |
RHINOVIRUS INFECTION |
202 |
0.0518 |
| 189 |
HERPES SIMPLEX |
336 |
0.0516 |
| 190 |
HISTIOCYTOSIS HAEMATOPHAGIC |
153 |
0.0515 |
| 191 |
CHRONIC LYMPHOCYTIC LEUKAEMIA |
244 |
0.0514 |
| 192 |
CYTOPENIA |
627 |
0.0512 |
| 193 |
BLOOD FOLLICLE STIMULATING HORMONE INCREASED |
20 |
0.0512 |
| 194 |
ACUTE MYELOID LEUKAEMIA |
792 |
0.0508 |
| 195 |
CAPILLARY LEAK SYNDROME |
103 |
0.0498 |
| 196 |
SECONDARY IMMUNODEFICIENCY |
60 |
0.0494 |
| 197 |
BLINDNESS CORTICAL |
24 |
0.0490 |
| 198 |
DIFFUSE LARGE B-CELL LYMPHOMA |
377 |
0.0489 |
| 199 |
HYPERFERRITINAEMIA |
21 |
0.0487 |
| 200 |
SERRATIA INFECTION |
36 |
0.0483 |
| 201 |
PSEUDOMONAL BACTERAEMIA |
41 |
0.0480 |
| 202 |
ASPERGILLOSIS |
62 |
0.0474 |
| 203 |
TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA |
31 |
0.0473 |
| 204 |
STAPHYLOCOCCAL BACTERAEMIA |
204 |
0.0469 |
| 205 |
ENTEROVIRUS INFECTION |
40 |
0.0463 |
| 206 |
CELLULITIS STAPHYLOCOCCAL |
30 |
0.0461 |
| 207 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
440 |
0.0460 |
| 208 |
ENTEROCOCCAL INFECTION |
222 |
0.0459 |
| 209 |
ESCHERICHIA SEPSIS |
133 |
0.0458 |
| 210 |
RESPIRATORY TRACT INFECTION FUNGAL |
24 |
0.0455 |
| 211 |
STAPHYLOCOCCAL SEPSIS |
222 |
0.0449 |
| 212 |
TRANSPLANT DYSFUNCTION |
80 |
0.0448 |
| 213 |
EVANS SYNDROME |
22 |
0.0446 |
| 214 |
CHRONIC MYELOID LEUKAEMIA RECURRENT |
24 |
0.0439 |
| 215 |
CYTOKINE STORM |
30 |
0.0438 |
| 216 |
MICROANGIOPATHY |
41 |
0.0436 |
| 217 |
FEBRILE NEUTROPENIA |
2871 |
0.0432 |
| 218 |
GASTROENTERITIS NOROVIRUS |
57 |
0.0429 |
| 219 |
EPSTEIN-BARR VIRUS TEST POSITIVE |
27 |
0.0428 |
| 220 |
THERAPY RESPONDER |
21 |
0.0428 |
| 221 |
LEUKOENCEPHALOPATHY |
159 |
0.0427 |
| 222 |
NEUROTOXICITY |
741 |
0.0422 |
| 223 |
DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY |
40 |
0.0422 |
| 224 |
MYELOPROLIFERATIVE NEOPLASM |
28 |
0.0422 |
| 225 |
ROTAVIRUS INFECTION |
24 |
0.0417 |
| 226 |
LOWER RESPIRATORY TRACT INFECTION VIRAL |
21 |
0.0415 |
| 227 |
CYTOMEGALOVIRUS COLITIS |
95 |
0.0413 |
| 228 |
BACTERAEMIA |
489 |
0.0412 |
| 229 |
CORYNEBACTERIUM INFECTION |
22 |
0.0411 |
| 230 |
METAPNEUMOVIRUS INFECTION |
32 |
0.0408 |
| 231 |
NEUTROPENIC INFECTION |
39 |
0.0408 |
| 232 |
PULMONARY VENO-OCCLUSIVE DISEASE |
28 |
0.0400 |
| 233 |
NOROVIRUS INFECTION |
57 |
0.0395 |
| 234 |
DIFFUSE ALVEOLAR DAMAGE |
45 |
0.0391 |
| 235 |
ESCHERICHIA BACTERAEMIA |
92 |
0.0391 |
| 236 |
DYSBIOSIS |
32 |
0.0390 |
| 237 |
ACUTE LYMPHOCYTIC LEUKAEMIA |
104 |
0.0367 |
| 238 |
DYSPLASIA |
44 |
0.0367 |
| 239 |
TUMOUR FLARE |
25 |
0.0366 |
| 240 |
BACILLUS INFECTION |
23 |
0.0364 |
| 241 |
BLOOD FIBRINOGEN DECREASED |
41 |
0.0359 |
| 242 |
N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED |
50 |
0.0356 |
| 243 |
PNEUMATOSIS INTESTINALIS |
101 |
0.0354 |
| 244 |
GENE MUTATION |
70 |
0.0353 |
| 245 |
PNEUMONIA KLEBSIELLA |
65 |
0.0353 |
| 246 |
STEROID DEPENDENCE |
31 |
0.0353 |
| 247 |
PNEUMOCOCCAL SEPSIS |
23 |
0.0350 |
| 248 |
PSEUDOMONAS INFECTION |
299 |
0.0348 |
| 249 |
BONE MARROW FAILURE |
705 |
0.0347 |
| 250 |
KLEBSIELLA INFECTION |
175 |
0.0346 |
| 251 |
HAEMATOLOGICAL INFECTION |
83 |
0.0339 |
| 252 |
HYPERLEUKOCYTOSIS |
30 |
0.0339 |
| 253 |
PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED |
20 |
0.0337 |
| 254 |
SECOND PRIMARY MALIGNANCY |
279 |
0.0335 |
| 255 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
931 |
0.0328 |
| 256 |
PNEUMOCYSTIS JIROVECII INFECTION |
39 |
0.0326 |
| 257 |
LYMPHOPROLIFERATIVE DISORDER |
95 |
0.0323 |
| 258 |
PULMONARY MYCOSIS |
25 |
0.0321 |
| 259 |
STREPTOCOCCAL SEPSIS |
37 |
0.0312 |
| 260 |
NEUTROPENIC COLITIS |
64 |
0.0309 |
| 261 |
T-LYMPHOCYTE COUNT DECREASED |
21 |
0.0308 |
| 262 |
BLOOD IMMUNOGLOBULIN G DECREASED |
76 |
0.0306 |
| 263 |
BONE MARROW TRANSPLANT |
58 |
0.0306 |
| 264 |
HEPATOSPLENOMEGALY |
78 |
0.0304 |
| 265 |
ENCEPHALITIS |
210 |
0.0303 |
| 266 |
HEPATITIS VIRAL |
24 |
0.0299 |
| 267 |
PNEUMONIA PSEUDOMONAL |
45 |
0.0293 |
| 268 |
HEPATITIS B REACTIVATION |
92 |
0.0290 |
| 269 |
LYMPHOCYTE COUNT DECREASED |
510 |
0.0288 |
| 270 |
HEPATITIS E |
45 |
0.0285 |
| 271 |
SKIN TOXICITY |
157 |
0.0278 |
| 272 |
MYELITIS |
43 |
0.0277 |
| 273 |
ENTEROBACTER INFECTION |
46 |
0.0273 |
| 274 |
DEMYELINATING POLYNEUROPATHY |
28 |
0.0272 |
| 275 |
IMMUNE THROMBOCYTOPENIA |
124 |
0.0271 |
| 276 |
PNEUMONIA INFLUENZAL |
32 |
0.0269 |
| 277 |
MENINGITIS CRYPTOCOCCAL |
47 |
0.0269 |
| 278 |
CENTRAL NERVOUS SYSTEM INFECTION |
30 |
0.0262 |
| 279 |
LYMPHOPENIA |
370 |
0.0261 |
| 280 |
LYMPHADENITIS |
63 |
0.0260 |
| 281 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
99 |
0.0259 |
| 282 |
SQUAMOUS CELL CARCINOMA OF SKIN |
156 |
0.0258 |
| 283 |
TUMOUR LYSIS SYNDROME |
226 |
0.0257 |
| 284 |
NEPHROPATHY TOXIC |
288 |
0.0256 |
| 285 |
NEUTROPENIC SEPSIS |
182 |
0.0255 |
| 286 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
67 |
0.0252 |
| 287 |
PANCYTOPENIA |
1408 |
0.0252 |
| 288 |
MUCOSAL DISORDER |
25 |
0.0252 |
| 289 |
CLOSTRIDIUM DIFFICILE COLITIS |
265 |
0.0250 |
| 290 |
MYCOBACTERIAL INFECTION |
43 |
0.0249 |
| 291 |
HERPES ZOSTER DISSEMINATED |
20 |
0.0249 |
| 292 |
PNEUMONIA VIRAL |
79 |
0.0248 |
| 293 |
IMMUNE THROMBOCYTOPENIC PURPURA |
70 |
0.0247 |
| 294 |
SOFT TISSUE INFECTION |
45 |
0.0246 |
| 295 |
NEOPLASM RECURRENCE |
83 |
0.0245 |
| 296 |
PULMONARY HAEMORRHAGE |
191 |
0.0244 |
| 297 |
MYELOPATHY |
46 |
0.0242 |
| 298 |
HYPOFIBRINOGENAEMIA |
24 |
0.0242 |
| 299 |
APLASIA PURE RED CELL |
83 |
0.0241 |
| 300 |
LUNG CONSOLIDATION |
67 |
0.0239 |
| 301 |
POLYOMAVIRUS-ASSOCIATED NEPHROPATHY |
56 |
0.0239 |
| 302 |
SERUM FERRITIN INCREASED |
126 |
0.0239 |
| 303 |
FEBRILE INFECTION |
28 |
0.0238 |
| 304 |
TUMOUR PSEUDOPROGRESSION |
26 |
0.0237 |
| 305 |
POLYMYOSITIS |
42 |
0.0237 |
| 306 |
BONE MARROW TOXICITY |
28 |
0.0236 |
| 307 |
PNEUMONIA STAPHYLOCOCCAL |
46 |
0.0233 |
| 308 |
PAROTITIS |
27 |
0.0233 |
| 309 |
PLASMA CELL MYELOMA REFRACTORY |
31 |
0.0232 |
| 310 |
GROWTH RETARDATION |
68 |
0.0231 |
| 311 |
NEUROLOGICAL DECOMPENSATION |
53 |
0.0229 |
| 312 |
BLOOD CULTURE POSITIVE |
68 |
0.0227 |
| 313 |
DEVICE RELATED SEPSIS |
45 |
0.0223 |
| 314 |
CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY |
32 |
0.0223 |
| 315 |
LIP ULCERATION |
26 |
0.0222 |
| 316 |
RENAL TUBULAR INJURY |
27 |
0.0222 |
| 317 |
TRANSPLANT REJECTION |
176 |
0.0219 |
| 318 |
IMMUNOGLOBULINS DECREASED |
30 |
0.0218 |
| 319 |
PULMONARY ALVEOLAR HAEMORRHAGE |
122 |
0.0217 |
| 320 |
ESCHERICHIA INFECTION |
178 |
0.0216 |
| 321 |
NEUROENDOCRINE CARCINOMA OF THE SKIN |
21 |
0.0215 |
| 322 |
IRON OVERLOAD |
23 |
0.0213 |
| 323 |
GASTROINTESTINAL VIRAL INFECTION |
22 |
0.0211 |
| 324 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
103 |
0.0206 |
| 325 |
MUCOUS MEMBRANE DISORDER |
28 |
0.0205 |
| 326 |
GLOMERULONEPHRITIS MEMBRANOUS |
24 |
0.0204 |
| 327 |
HAEMOPHILUS INFECTION |
20 |
0.0204 |
| 328 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
204 |
0.0203 |
| 329 |
HAEMATOTOXICITY |
193 |
0.0203 |
| 330 |
PARAPARESIS |
36 |
0.0202 |
| 331 |
KIDNEY FIBROSIS |
35 |
0.0202 |
| 332 |
SEPTIC SHOCK |
873 |
0.0200 |
| 333 |
HAEMATOLOGICAL MALIGNANCY |
57 |
0.0200 |
| 334 |
BRAIN ABSCESS |
50 |
0.0197 |
| 335 |
PNEUMOCYSTIS JIROVECI PNEUMONIA |
44 |
0.0197 |
| 336 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
349 |
0.0197 |
| 337 |
MENINGITIS BACTERIAL |
28 |
0.0196 |
| 338 |
NOCARDIOSIS |
50 |
0.0195 |
| 339 |
HYPOALBUMINAEMIA |
151 |
0.0194 |
| 340 |
LYMPHOCYTOSIS |
41 |
0.0190 |
| 341 |
VARICELLA |
45 |
0.0188 |
| 342 |
GASTROINTESTINAL TOXICITY |
90 |
0.0187 |
| 343 |
HEPATITIS B |
111 |
0.0184 |
| 344 |
ORGANISING PNEUMONIA |
91 |
0.0183 |
| 345 |
ACINETOBACTER INFECTION |
20 |
0.0183 |
| 346 |
PNEUMONIA STREPTOCOCCAL |
20 |
0.0182 |
| 347 |
BACTERIAL INFECTION |
339 |
0.0182 |
| 348 |
MULTI-ORGAN FAILURE |
311 |
0.0180 |
| 349 |
B-CELL LYMPHOMA |
61 |
0.0179 |
| 350 |
CYTOGENETIC ABNORMALITY |
20 |
0.0177 |
| 351 |
PNEUMONIA BACTERIAL |
162 |
0.0176 |
| 352 |
MENINGITIS VIRAL |
24 |
0.0175 |
| 353 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
152 |
0.0174 |
| 354 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
106 |
0.0174 |
| 355 |
MUCOSAL HAEMORRHAGE |
20 |
0.0172 |
| 356 |
MANTLE CELL LYMPHOMA |
26 |
0.0171 |
| 357 |
NON-HODGKIN'S LYMPHOMA |
22 |
0.0168 |
| 358 |
LYMPHOMA |
257 |
0.0166 |
| 359 |
PNEUMOMEDIASTINUM |
30 |
0.0166 |
| 360 |
FEBRILE BONE MARROW APLASIA |
70 |
0.0165 |
| 361 |
H1N1 INFLUENZA |
23 |
0.0164 |
| 362 |
HERPES VIRUS INFECTION |
94 |
0.0163 |
| 363 |
URINARY TRACT INFECTION BACTERIAL |
41 |
0.0162 |
| 364 |
DISSEMINATED TUBERCULOSIS |
41 |
0.0160 |
| 365 |
GUILLAIN-BARRE SYNDROME |
77 |
0.0159 |
| 366 |
CUSHINGOID |
51 |
0.0159 |
| 367 |
RESPIRATORY TRACT INFECTION VIRAL |
37 |
0.0159 |
| 368 |
NEUTROPHIL COUNT DECREASED |
643 |
0.0158 |
| 369 |
HAEMOLYSIS |
121 |
0.0157 |
| 370 |
ENCEPHALOPATHY |
384 |
0.0156 |
| 371 |
ADENOCARCINOMA OF COLON |
29 |
0.0155 |
| 372 |
CANDIDA INFECTION |
261 |
0.0154 |
| 373 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
158 |
0.0154 |
| 374 |
DISSEMINATED INTRAVASCULAR COAGULATION |
216 |
0.0153 |
| 375 |
STEROID DIABETES |
23 |
0.0153 |
| 376 |
PHARYNGEAL ULCERATION |
20 |
0.0151 |
| 377 |
AUTOIMMUNE THYROIDITIS |
57 |
0.0151 |
| 378 |
NEUTROPENIA |
2047 |
0.0150 |
| 379 |
THROMBOCYTOPENIA |
1680 |
0.0150 |
| 380 |
RECURRENT CANCER |
61 |
0.0149 |
| 381 |
LICHENOID KERATOSIS |
34 |
0.0149 |
| 382 |
HAEMATOCRIT DECREASED |
293 |
0.0148 |
| 383 |
HYPERBILIRUBINAEMIA |
153 |
0.0148 |
| 384 |
LUNG ADENOCARCINOMA |
44 |
0.0146 |
| 385 |
OPPORTUNISTIC INFECTION |
27 |
0.0146 |
| 386 |
CARDIOTOXICITY |
130 |
0.0146 |
| 387 |
HYPOXIA |
513 |
0.0146 |
| 388 |
GENERALISED OEDEMA |
179 |
0.0144 |
| 389 |
MYELITIS TRANSVERSE |
20 |
0.0142 |
| 390 |
SEPSIS |
1576 |
0.0141 |
| 391 |
SQUAMOUS CELL CARCINOMA |
131 |
0.0139 |
| 392 |
RESPIRATORY FAILURE |
1013 |
0.0139 |
| 393 |
VACCINATION FAILURE |
23 |
0.0138 |
| 394 |
FUNGAL INFECTION |
461 |
0.0138 |
| 395 |
STAPHYLOCOCCUS TEST POSITIVE |
29 |
0.0137 |
| 396 |
BRAIN HERNIATION |
41 |
0.0137 |
| 397 |
PORTAL HYPERTENSION |
42 |
0.0136 |
| 398 |
HYDROCEPHALUS |
73 |
0.0134 |
| 399 |
MULTIPLE-DRUG RESISTANCE |
41 |
0.0132 |
| 400 |
DRUG RESISTANCE |
339 |
0.0132 |
| 401 |
STAPHYLOCOCCAL INFECTION |
435 |
0.0132 |
| 402 |
HAEMOLYTIC ANAEMIA |
117 |
0.0130 |
| 403 |
LUNG INFILTRATION |
115 |
0.0130 |
| 404 |
HEPATIC NECROSIS |
49 |
0.0130 |
| 405 |
HYPOPHOSPHATAEMIA |
96 |
0.0130 |
| 406 |
LEFT VENTRICULAR DYSFUNCTION |
87 |
0.0130 |
| 407 |
ENTEROCOLITIS |
74 |
0.0128 |
| 408 |
HYPOPROTEINAEMIA |
24 |
0.0126 |
| 409 |
METASTATIC MALIGNANT MELANOMA |
29 |
0.0126 |
| 410 |
VITILIGO |
29 |
0.0124 |
| 411 |
PLASMACYTOMA |
23 |
0.0123 |
| 412 |
THERAPY PARTIAL RESPONDER |
191 |
0.0122 |
| 413 |
CARDIAC TAMPONADE |
58 |
0.0122 |
| 414 |
CLOSTRIDIUM DIFFICILE INFECTION |
266 |
0.0122 |
| 415 |
PATHOGEN RESISTANCE |
111 |
0.0122 |
| 416 |
DEVICE RELATED INFECTION |
187 |
0.0121 |
| 417 |
NEUROLOGICAL SYMPTOM |
69 |
0.0121 |
| 418 |
LUNG OPACITY |
31 |
0.0118 |
| 419 |
PULMONARY TOXICITY |
82 |
0.0116 |
| 420 |
LYMPH NODE PAIN |
21 |
0.0113 |
| 421 |
SPLENOMEGALY |
131 |
0.0112 |
| 422 |
ACTINIC KERATOSIS |
29 |
0.0112 |
| 423 |
LYMPHADENOPATHY |
395 |
0.0111 |
| 424 |
BASAL CELL CARCINOMA |
174 |
0.0111 |
| 425 |
TOXIC ENCEPHALOPATHY |
56 |
0.0110 |
| 426 |
MYELOSUPPRESSION |
398 |
0.0110 |
| 427 |
RESPIRATORY DISTRESS |
303 |
0.0110 |
| 428 |
PERICARDIAL EFFUSION |
253 |
0.0109 |
| 429 |
CLOSTRIDIAL INFECTION |
37 |
0.0109 |
| 430 |
CLOSTRIDIUM TEST POSITIVE |
24 |
0.0109 |
| 431 |
HEPATOMEGALY |
106 |
0.0108 |
| 432 |
CD4 LYMPHOCYTES DECREASED |
23 |
0.0107 |
| 433 |
HEPATIC FAILURE |
320 |
0.0106 |
| 434 |
BRAIN OEDEMA |
134 |
0.0106 |
| 435 |
SUBDURAL HAEMORRHAGE |
29 |
0.0106 |
| 436 |
COVID-19 PNEUMONIA |
125 |
0.0106 |
| 437 |
HEPATOTOXICITY |
230 |
0.0103 |
| 438 |
HYPERPHOSPHATAEMIA |
22 |
0.0102 |
| 439 |
HEART RATE ABNORMAL |
55 |
0.0099 |
| 440 |
INFECTION |
1413 |
0.0098 |
| 441 |
THROMBOTIC THROMBOCYTOPENIC PURPURA |
34 |
0.0096 |
| 442 |
OESOPHAGEAL CANDIDIASIS |
38 |
0.0095 |
| 443 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
151 |
0.0095 |
| 444 |
HYPERVOLAEMIA |
47 |
0.0095 |
| 445 |
HAEMOLYTIC URAEMIC SYNDROME |
22 |
0.0095 |
| 446 |
INFLAMMATORY MARKER INCREASED |
47 |
0.0095 |
| 447 |
PARESIS |
21 |
0.0094 |
| 448 |
ENTERITIS |
60 |
0.0094 |
| 449 |
FUNGAL SKIN INFECTION |
37 |
0.0092 |
| 450 |
GASTROINTESTINAL INFECTION |
82 |
0.0091 |
| 451 |
DISEASE PROGRESSION |
1077 |
0.0091 |
| 452 |
PRODUCT USE IN UNAPPROVED INDICATION |
2252 |
0.0091 |
| 453 |
BLOOD BILIRUBIN INCREASED |
244 |
0.0090 |
| 454 |
DEMYELINATION |
37 |
0.0090 |
| 455 |
SUSPECTED OFF LABEL USE |
40 |
0.0088 |
| 456 |
RETINAL HAEMORRHAGE |
63 |
0.0088 |
| 457 |
ATYPICAL PNEUMONIA |
26 |
0.0087 |
| 458 |
PULMONARY TUBERCULOSIS |
37 |
0.0087 |
| 459 |
PYREXIA |
2965 |
0.0086 |
| 460 |
ACUTE RESPIRATORY FAILURE |
164 |
0.0085 |
| 461 |
ASCITES |
248 |
0.0084 |
| 462 |
HAEMORRHAGE INTRACRANIAL |
126 |
0.0084 |
| 463 |
HAEMODYNAMIC INSTABILITY |
64 |
0.0084 |
| 464 |
VASCULAR DEVICE INFECTION |
38 |
0.0084 |
| 465 |
BONE MARROW DISORDER |
25 |
0.0083 |
| 466 |
MENINGITIS |
55 |
0.0082 |
| 467 |
C-REACTIVE PROTEIN INCREASED |
296 |
0.0081 |
| 468 |
PLEURAL EFFUSION |
494 |
0.0081 |
| 469 |
PLATELET COUNT DECREASED |
857 |
0.0080 |
| 470 |
HYPERURICAEMIA |
33 |
0.0080 |
| 471 |
HYPOXIC-ISCHAEMIC ENCEPHALOPATHY |
21 |
0.0080 |
| 472 |
HYPERAMMONAEMIA |
40 |
0.0080 |
| 473 |
PARONYCHIA |
35 |
0.0080 |
| 474 |
BRONCHIOLITIS |
28 |
0.0079 |
| 475 |
ORGAN FAILURE |
32 |
0.0079 |
| 476 |
IMMUNOSUPPRESSION |
70 |
0.0079 |
| 477 |
AGRANULOCYTOSIS |
147 |
0.0079 |
| 478 |
SERUM SICKNESS |
22 |
0.0079 |
| 479 |
GASTROINTESTINAL NECROSIS |
23 |
0.0079 |
| 480 |
CARDIAC DYSFUNCTION |
29 |
0.0078 |
| 481 |
CARDIOPULMONARY FAILURE |
30 |
0.0077 |
| 482 |
ANOREXIA |
99 |
0.0077 |
| 483 |
METABOLIC ENCEPHALOPATHY |
23 |
0.0077 |
| 484 |
CARDIAC FAILURE ACUTE |
51 |
0.0076 |
| 485 |
MYOSITIS |
68 |
0.0076 |
| 486 |
VIRAL UPPER RESPIRATORY TRACT INFECTION |
36 |
0.0076 |
| 487 |
OLIGURIA |
47 |
0.0076 |
| 488 |
RASH MACULO-PAPULAR |
168 |
0.0075 |
| 489 |
DUODENITIS |
23 |
0.0075 |
| 490 |
CANDIDIASIS |
30 |
0.0075 |
| 491 |
MALIGNANT MELANOMA |
99 |
0.0074 |
| 492 |
VENOUS THROMBOSIS |
29 |
0.0074 |
| 493 |
APHASIA |
221 |
0.0073 |
| 494 |
BRONCHOPNEUMONIA |
25 |
0.0073 |
| 495 |
NEPHROTIC SYNDROME |
50 |
0.0073 |
| 496 |
GRANULOCYTOPENIA |
41 |
0.0072 |
| 497 |
ATELECTASIS |
69 |
0.0071 |
| 498 |
THERAPY NON-RESPONDER |
321 |
0.0071 |
| 499 |
ACUTE PULMONARY OEDEMA |
40 |
0.0071 |
| 500 |
STOMATITIS |
431 |
0.0071 |
| 501 |
MALNUTRITION |
79 |
0.0071 |
| 502 |
HYPERTRANSAMINASAEMIA |
49 |
0.0070 |
| 503 |
RENAL TUBULAR NECROSIS |
69 |
0.0070 |
| 504 |
NEOPLASM PROGRESSION |
243 |
0.0070 |
| 505 |
WHITE BLOOD CELL COUNT DECREASED |
756 |
0.0070 |
| 506 |
LEUKOPENIA |
348 |
0.0070 |
| 507 |
FAILURE TO THRIVE |
36 |
0.0069 |
| 508 |
CHRONIC MYELOID LEUKAEMIA |
32 |
0.0069 |
| 509 |
NON-SMALL CELL LUNG CANCER |
33 |
0.0069 |
| 510 |
MENTAL STATUS CHANGES |
190 |
0.0068 |
| 511 |
BLOOD MAGNESIUM DECREASED |
59 |
0.0068 |
| 512 |
NECROSIS |
38 |
0.0068 |
| 513 |
NO THERAPEUTIC RESPONSE |
83 |
0.0068 |
| 514 |
PNEUMONITIS |
184 |
0.0068 |
| 515 |
SHOCK HAEMORRHAGIC |
55 |
0.0067 |
| 516 |
CARDIOMYOPATHY |
99 |
0.0067 |
| 517 |
COAGULOPATHY |
111 |
0.0067 |
| 518 |
STATUS EPILEPTICUS |
75 |
0.0066 |
| 519 |
ENDOCARDITIS |
34 |
0.0066 |
| 520 |
PYELONEPHRITIS |
57 |
0.0066 |
| 521 |
HYPERTHERMIA |
50 |
0.0065 |
| 522 |
RENAL CELL CARCINOMA |
32 |
0.0065 |
| 523 |
SKIN EROSION |
21 |
0.0065 |
| 524 |
FIBROSIS |
20 |
0.0065 |
| 525 |
PULSELESS ELECTRICAL ACTIVITY |
27 |
0.0065 |
| 526 |
VIRAL INFECTION |
214 |
0.0064 |
| 527 |
OESOPHAGITIS |
70 |
0.0064 |
| 528 |
HYPERPYREXIA |
27 |
0.0064 |
| 529 |
SCLERODERMA |
23 |
0.0063 |
| 530 |
MALIGNANT NEOPLASM PROGRESSION |
643 |
0.0063 |
| 531 |
AZOTAEMIA |
25 |
0.0063 |
| 532 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
342 |
0.0062 |
| 533 |
MYOCARDITIS |
71 |
0.0062 |
| 534 |
DISEASE RECURRENCE |
294 |
0.0062 |
| 535 |
ACIDOSIS |
47 |
0.0061 |
| 536 |
MALABSORPTION |
32 |
0.0061 |
| 537 |
ESCHERICHIA URINARY TRACT INFECTION |
26 |
0.0061 |
| 538 |
TACHYPNOEA |
83 |
0.0061 |
| 539 |
ARTHRITIS BACTERIAL |
25 |
0.0061 |
| 540 |
ACUTE KIDNEY INJURY |
932 |
0.0061 |
| 541 |
HERPES ZOSTER |
347 |
0.0060 |
| 542 |
ORAL DISORDER |
44 |
0.0060 |
| 543 |
SKIN MASS |
40 |
0.0060 |
| 544 |
ANAL ABSCESS |
32 |
0.0059 |
| 545 |
BLOOD ALBUMIN DECREASED |
47 |
0.0059 |
| 546 |
INTRACRANIAL PRESSURE INCREASED |
33 |
0.0059 |
| 547 |
HYPOMAGNESAEMIA |
82 |
0.0059 |
| 548 |
COLITIS |
223 |
0.0059 |
| 549 |
CACHEXIA |
30 |
0.0058 |
| 550 |
LEUKAEMIA |
55 |
0.0058 |
| 551 |
HEPATIC FIBROSIS |
20 |
0.0058 |
| 552 |
PERIPHERAL SENSORY NEUROPATHY |
34 |
0.0058 |
| 553 |
TRANSAMINASES INCREASED |
129 |
0.0058 |
| 554 |
HEPATIC LESION |
25 |
0.0058 |
| 555 |
CONGESTIVE CARDIOMYOPATHY |
24 |
0.0058 |
| 556 |
GASTROINTESTINAL INFLAMMATION |
45 |
0.0057 |
| 557 |
OESOPHAGEAL ULCER |
22 |
0.0057 |
| 558 |
NECROTISING FASCIITIS |
20 |
0.0057 |
| 559 |
ANAEMIA |
1078 |
0.0056 |
| 560 |
DYSGRAPHIA |
37 |
0.0056 |
| 561 |
ILEUS PARALYTIC |
25 |
0.0056 |
| 562 |
POLYNEUROPATHY |
67 |
0.0056 |
| 563 |
DRUG TOXICITY |
76 |
0.0056 |
| 564 |
HEPATIC ENCEPHALOPATHY |
52 |
0.0056 |
| 565 |
CEREBRAL HAEMORRHAGE |
198 |
0.0055 |
| 566 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
122 |
0.0055 |
| 567 |
BLOOD DISORDER |
44 |
0.0055 |
| 568 |
HEMIPARESIS |
93 |
0.0055 |
| 569 |
TOXIC EPIDERMAL NECROLYSIS |
83 |
0.0055 |
| 570 |
ANURIA |
47 |
0.0055 |
| 571 |
MOUTH HAEMORRHAGE |
40 |
0.0055 |
| 572 |
HAEMATURIA |
186 |
0.0054 |
| 573 |
STREPTOCOCCAL INFECTION |
30 |
0.0054 |
| 574 |
LUNG NEOPLASM |
23 |
0.0054 |
| 575 |
HAEMOGLOBIN DECREASED |
552 |
0.0054 |
| 576 |
MENINGITIS ASEPTIC |
24 |
0.0053 |
| 577 |
HYPOCALCAEMIA |
101 |
0.0053 |
| 578 |
SKIN LESION |
146 |
0.0053 |
| 579 |
NEOPLASM |
61 |
0.0053 |
| 580 |
CHOLESTASIS |
101 |
0.0053 |
| 581 |
DIARRHOEA HAEMORRHAGIC |
49 |
0.0052 |
| 582 |
ASPARTATE AMINOTRANSFERASE INCREASED |
278 |
0.0052 |
| 583 |
LUNG INFECTION |
81 |
0.0052 |
| 584 |
PROTHROMBIN TIME PROLONGED |
31 |
0.0052 |
| 585 |
OFF LABEL USE |
4520 |
0.0052 |
| 586 |
EJECTION FRACTION DECREASED |
80 |
0.0051 |
| 587 |
ATAXIA |
61 |
0.0051 |
| 588 |
CORONAVIRUS INFECTION |
33 |
0.0050 |
| 589 |
TRANSFUSION |
52 |
0.0050 |
| 590 |
HEPATIC CYTOLYSIS |
63 |
0.0049 |
| 591 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
25 |
0.0049 |
| 592 |
ILEUS |
61 |
0.0049 |
| 593 |
BRONCHIECTASIS |
33 |
0.0049 |
| 594 |
SUBDURAL HAEMATOMA |
70 |
0.0049 |
| 595 |
HAEMODIALYSIS |
41 |
0.0049 |
| 596 |
LUNG DISORDER |
239 |
0.0049 |
| 597 |
ACUTE HEPATIC FAILURE |
66 |
0.0048 |
| 598 |
HYDRONEPHROSIS |
36 |
0.0048 |
| 599 |
HEPATITIS |
123 |
0.0048 |
| 600 |
PURPURA |
42 |
0.0047 |
| 601 |
METASTASIS |
33 |
0.0046 |
| 602 |
ALANINE AMINOTRANSFERASE INCREASED |
283 |
0.0046 |
| 603 |
METASTASES TO LYMPH NODES |
31 |
0.0046 |
| 604 |
HYPOKALAEMIA |
212 |
0.0046 |
| 605 |
RENAL FAILURE |
606 |
0.0046 |
| 606 |
PNEUMOTHORAX |
72 |
0.0045 |
| 607 |
PNEUMONIA |
1469 |
0.0045 |
| 608 |
ADRENAL INSUFFICIENCY |
55 |
0.0045 |
| 609 |
RENAL IMPAIRMENT |
375 |
0.0045 |
| 610 |
ANGIOPATHY |
25 |
0.0045 |
| 611 |
AUTOIMMUNE HEPATITIS |
31 |
0.0045 |
| 612 |
HYPERTRIGLYCERIDAEMIA |
26 |
0.0044 |
| 613 |
PULMONARY MASS |
66 |
0.0044 |
| 614 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
110 |
0.0044 |
| 615 |
OSTEOPENIA |
66 |
0.0043 |
| 616 |
FACIAL PARALYSIS |
37 |
0.0043 |
| 617 |
TUBULOINTERSTITIAL NEPHRITIS |
81 |
0.0043 |
| 618 |
PETECHIAE |
45 |
0.0043 |
| 619 |
HYPOTENSION |
862 |
0.0043 |
| 620 |
VISUAL FIELD DEFECT |
31 |
0.0043 |
| 621 |
MYOPATHY |
37 |
0.0043 |
| 622 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
169 |
0.0043 |
| 623 |
PULMONARY OEDEMA |
191 |
0.0043 |
| 624 |
ATRIAL FLUTTER |
34 |
0.0043 |
| 625 |
BREATH SOUNDS ABNORMAL |
21 |
0.0043 |
| 626 |
RESPIRATORY DISORDER |
127 |
0.0042 |
| 627 |
PERONEAL NERVE PALSY |
24 |
0.0042 |
| 628 |
ONYCHOCLASIS |
29 |
0.0042 |
| 629 |
TREATMENT FAILURE |
349 |
0.0042 |
| 630 |
CHOLECYSTITIS |
50 |
0.0042 |
| 631 |
SKIN INFECTION |
47 |
0.0042 |
| 632 |
HEPATIC FUNCTION ABNORMAL |
156 |
0.0042 |
| 633 |
EXERCISE TOLERANCE DECREASED |
24 |
0.0042 |
| 634 |
NERVOUS SYSTEM DISORDER |
128 |
0.0041 |
| 635 |
PULMONARY CONGESTION |
54 |
0.0041 |
| 636 |
CELLULITIS |
206 |
0.0041 |
| 637 |
CARDIAC FAILURE |
328 |
0.0041 |
| 638 |
ELECTROLYTE IMBALANCE |
47 |
0.0040 |
| 639 |
MOTOR DYSFUNCTION |
41 |
0.0040 |
| 640 |
ALTERED STATE OF CONSCIOUSNESS |
87 |
0.0040 |
| 641 |
AUTOIMMUNE DISORDER |
39 |
0.0040 |
| 642 |
PARKINSONISM |
39 |
0.0040 |
| 643 |
RESPIRATORY TRACT INFECTION |
103 |
0.0040 |
| 644 |
RENAL FAILURE ACUTE |
166 |
0.0039 |
| 645 |
MUSCLE TWITCHING |
90 |
0.0039 |
| 646 |
HEPATOCELLULAR INJURY |
55 |
0.0039 |
| 647 |
ECCHYMOSIS |
26 |
0.0038 |
| 648 |
APPENDICITIS |
35 |
0.0037 |
| 649 |
SHOCK |
86 |
0.0037 |
| 650 |
ATRIAL FIBRILLATION |
364 |
0.0037 |
| 651 |
PROCTALGIA |
24 |
0.0037 |
| 652 |
SINUS TACHYCARDIA |
53 |
0.0037 |
| 653 |
HYPERCALCAEMIA |
46 |
0.0037 |
| 654 |
ODYNOPHAGIA |
22 |
0.0037 |
| 655 |
PULMONARY HYPERTENSION |
76 |
0.0036 |
| 656 |
ORAL CANDIDIASIS |
48 |
0.0036 |
| 657 |
INTERSTITIAL LUNG DISEASE |
176 |
0.0036 |
| 658 |
SUBARACHNOID HAEMORRHAGE |
37 |
0.0036 |
| 659 |
PERICARDITIS |
61 |
0.0036 |
| 660 |
CYSTITIS |
115 |
0.0036 |
| 661 |
INTENTIONAL PRODUCT USE ISSUE |
314 |
0.0036 |
| 662 |
TOXIC SKIN ERUPTION |
36 |
0.0036 |
| 663 |
DUODENAL ULCER |
25 |
0.0035 |
| 664 |
FLUID OVERLOAD |
51 |
0.0035 |
| 665 |
CARDIOGENIC SHOCK |
50 |
0.0035 |
| 666 |
APNOEA |
27 |
0.0035 |
| 667 |
PNEUMONIA ASPIRATION |
86 |
0.0034 |
| 668 |
ORAL HERPES |
67 |
0.0034 |
| 669 |
CENTRAL NERVOUS SYSTEM LESION |
47 |
0.0034 |
| 670 |
PLASMA CELL MYELOMA |
133 |
0.0034 |
| 671 |
TACHYCARDIA |
302 |
0.0034 |
| 672 |
HEMIPLEGIA |
28 |
0.0034 |
| 673 |
URINE OUTPUT DECREASED |
29 |
0.0033 |
| 674 |
MELAENA |
73 |
0.0033 |
| 675 |
PULMONARY ARTERIAL HYPERTENSION |
48 |
0.0033 |
| 676 |
WHITE BLOOD CELL COUNT ABNORMAL |
21 |
0.0033 |
| 677 |
BLOOD UREA INCREASED |
55 |
0.0033 |
| 678 |
LEUKOCYTOSIS |
59 |
0.0033 |
| 679 |
OSTEONECROSIS |
107 |
0.0033 |
| 680 |
PROTEINURIA |
60 |
0.0032 |
| 681 |
UROSEPSIS |
29 |
0.0031 |
| 682 |
INTESTINAL PERFORATION |
35 |
0.0031 |
| 683 |
BLOOD CREATININE INCREASED |
201 |
0.0031 |
| 684 |
ABSCESS |
49 |
0.0031 |
| 685 |
JOINT EFFUSION |
21 |
0.0030 |
| 686 |
LIVER FUNCTION TEST INCREASED |
65 |
0.0030 |
| 687 |
DELIRIUM |
105 |
0.0030 |
| 688 |
TOXICITY TO VARIOUS AGENTS |
510 |
0.0030 |
| 689 |
GLOMERULAR FILTRATION RATE DECREASED |
37 |
0.0030 |
| 690 |
EMBOLISM |
25 |
0.0030 |
| 691 |
SENSORY LOSS |
24 |
0.0030 |
| 692 |
EPILEPSY |
90 |
0.0029 |
| 693 |
GASTROINTESTINAL HAEMORRHAGE |
246 |
0.0029 |
| 694 |
UPPER RESPIRATORY TRACT INFECTION |
135 |
0.0029 |
| 695 |
DERMATITIS BULLOUS |
21 |
0.0029 |
| 696 |
LIVER DISORDER |
128 |
0.0029 |
| 697 |
RASH PUSTULAR |
21 |
0.0029 |
| 698 |
GASTROENTERITIS |
42 |
0.0029 |
| 699 |
NEUROPATHY PERIPHERAL |
272 |
0.0029 |
| 700 |
DISORIENTATION |
113 |
0.0028 |
| 701 |
MYOCLONUS |
34 |
0.0028 |
| 702 |
MOUTH ULCERATION |
60 |
0.0028 |
| 703 |
HYPERGLYCAEMIA |
103 |
0.0028 |
| 704 |
HAEMOPTYSIS |
78 |
0.0028 |
| 705 |
HYPONATRAEMIA |
157 |
0.0028 |
| 706 |
FOLLICULITIS |
29 |
0.0028 |
| 707 |
RHINITIS |
22 |
0.0027 |
| 708 |
CEREBRAL DISORDER |
20 |
0.0027 |
| 709 |
DIPLOPIA |
70 |
0.0027 |
| 710 |
SKIN HYPERPIGMENTATION |
23 |
0.0027 |
| 711 |
FACE OEDEMA |
45 |
0.0027 |
| 712 |
GENERALISED TONIC-CLONIC SEIZURE |
44 |
0.0027 |
| 713 |
ASPIRATION |
29 |
0.0026 |
| 714 |
OPTIC NEURITIS |
24 |
0.0026 |
| 715 |
JAUNDICE |
71 |
0.0026 |
| 716 |
HEPATIC STEATOSIS |
49 |
0.0026 |
| 717 |
IMMUNODEFICIENCY |
39 |
0.0026 |
| 718 |
HYPERTENSION |
552 |
0.0026 |
| 719 |
CARDIOMEGALY |
32 |
0.0026 |
| 720 |
BLINDNESS |
105 |
0.0026 |
| 721 |
PRODUCTIVE COUGH |
123 |
0.0026 |
| 722 |
VASCULITIS |
30 |
0.0026 |
| 723 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
75 |
0.0026 |
| 724 |
SEIZURE |
294 |
0.0025 |
| 725 |
DRUG ADMINISTRATION ERROR |
77 |
0.0025 |
| 726 |
PHARYNGITIS |
31 |
0.0025 |
| 727 |
PANCREATITIS ACUTE |
56 |
0.0025 |
| 728 |
CHILLS |
290 |
0.0025 |
| 729 |
CONFUSIONAL STATE |
399 |
0.0025 |
| 730 |
COMA |
117 |
0.0025 |
| 731 |
BLOOD COUNT ABNORMAL |
37 |
0.0024 |
| 732 |
METABOLIC ACIDOSIS |
78 |
0.0024 |
| 733 |
GASTRITIS |
64 |
0.0024 |
| 734 |
CONJUNCTIVITIS |
45 |
0.0024 |
| 735 |
BODY TEMPERATURE INCREASED |
49 |
0.0024 |
| 736 |
GENERAL PHYSICAL HEALTH DETERIORATION |
276 |
0.0024 |
| 737 |
INFUSION RELATED REACTION |
158 |
0.0024 |
| 738 |
EYELID PTOSIS |
24 |
0.0024 |
| 739 |
THERAPEUTIC RESPONSE DECREASED |
143 |
0.0024 |
| 740 |
TOOTH INFECTION |
31 |
0.0023 |
| 741 |
HYPOPHAGIA |
60 |
0.0023 |
| 742 |
HEPATIC CIRRHOSIS |
44 |
0.0023 |
| 743 |
VENTRICULAR FIBRILLATION |
26 |
0.0023 |
| 744 |
DYSURIA |
86 |
0.0023 |
| 745 |
CEREBRAL INFARCTION |
57 |
0.0023 |
| 746 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
39 |
0.0023 |
| 747 |
LIVER FUNCTION TEST ABNORMAL |
67 |
0.0023 |
| 748 |
DRUG INEFFECTIVE |
3025 |
0.0023 |
| 749 |
DRUG-INDUCED LIVER INJURY |
72 |
0.0023 |
| 750 |
CIRCULATORY COLLAPSE |
39 |
0.0023 |
| 751 |
COVID-19 |
401 |
0.0023 |
| 752 |
CARDIAC ARREST |
188 |
0.0023 |
| 753 |
IMMUNE SYSTEM DISORDER |
30 |
0.0023 |
| 754 |
IMPAIRED GASTRIC EMPTYING |
31 |
0.0023 |
| 755 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
53 |
0.0023 |
| 756 |
SKIN REACTION |
31 |
0.0022 |
| 757 |
BRAIN INJURY |
22 |
0.0022 |
| 758 |
ISCHAEMIC STROKE |
39 |
0.0022 |
| 759 |
BLOOD PRESSURE DECREASED |
143 |
0.0022 |
| 760 |
DRUG ERUPTION |
38 |
0.0021 |
| 761 |
RED BLOOD CELL COUNT DECREASED |
61 |
0.0021 |
| 762 |
BLINDNESS UNILATERAL |
30 |
0.0021 |
| 763 |
SMALL INTESTINAL OBSTRUCTION |
26 |
0.0021 |
| 764 |
WHITE BLOOD CELL COUNT INCREASED |
81 |
0.0021 |
| 765 |
FULL BLOOD COUNT DECREASED |
42 |
0.0021 |
| 766 |
METASTASES TO LIVER |
36 |
0.0020 |
| 767 |
OEDEMA |
110 |
0.0020 |
| 768 |
THROMBOSIS |
162 |
0.0020 |
| 769 |
HAEMORRHAGE |
208 |
0.0020 |
| 770 |
OBSTRUCTIVE AIRWAYS DISORDER |
22 |
0.0020 |
| 771 |
NEUTROPHIL COUNT INCREASED |
20 |
0.0020 |
| 772 |
PRODUCT USE ISSUE |
367 |
0.0020 |
| 773 |
SKIN CANCER |
42 |
0.0019 |
| 774 |
MITRAL VALVE INCOMPETENCE |
22 |
0.0019 |
| 775 |
STEVENS-JOHNSON SYNDROME |
43 |
0.0019 |
| 776 |
END STAGE RENAL DISEASE |
35 |
0.0019 |
| 777 |
LIVER INJURY |
47 |
0.0019 |
| 778 |
LOWER RESPIRATORY TRACT INFECTION |
87 |
0.0019 |
| 779 |
RENAL DISORDER |
89 |
0.0019 |
| 780 |
PULMONARY EMBOLISM |
181 |
0.0019 |
| 781 |
METASTASES TO LUNG |
22 |
0.0019 |
| 782 |
MUSCULAR WEAKNESS |
216 |
0.0019 |
| 783 |
MASS |
26 |
0.0019 |
| 784 |
REBOUND EFFECT |
21 |
0.0019 |
| 785 |
HYPOTHYROIDISM |
59 |
0.0018 |
| 786 |
HEPATIC ENZYME INCREASED |
124 |
0.0018 |
| 787 |
COLON CANCER |
27 |
0.0018 |
| 788 |
DEEP VEIN THROMBOSIS |
117 |
0.0018 |
| 789 |
HYPERKALAEMIA |
63 |
0.0018 |
| 790 |
CARDIO-RESPIRATORY ARREST |
75 |
0.0018 |
| 791 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
23 |
0.0018 |
| 792 |
LUNG NEOPLASM MALIGNANT |
73 |
0.0018 |
| 793 |
INFLAMMATION |
91 |
0.0018 |
| 794 |
DIALYSIS |
25 |
0.0018 |
| 795 |
COGNITIVE DISORDER |
82 |
0.0018 |
| 796 |
BLOOD SODIUM DECREASED |
33 |
0.0017 |
| 797 |
SINUSITIS |
179 |
0.0017 |
| 798 |
MYDRIASIS |
22 |
0.0017 |
| 799 |
NIGHT SWEATS |
55 |
0.0017 |
| 800 |
OEDEMA PERIPHERAL |
205 |
0.0017 |
| 801 |
BRADYCARDIA |
89 |
0.0017 |
| 802 |
HYPERLIPIDAEMIA |
20 |
0.0017 |
| 803 |
OXYGEN SATURATION DECREASED |
94 |
0.0017 |
| 804 |
POST PROCEDURAL COMPLICATION |
32 |
0.0017 |
| 805 |
CONVULSION |
95 |
0.0017 |
| 806 |
DRUG INTOLERANCE |
159 |
0.0016 |
| 807 |
FRACTURE |
31 |
0.0016 |
| 808 |
DIARRHOEA |
1048 |
0.0016 |
| 809 |
GASTROINTESTINAL DISORDER |
144 |
0.0016 |
| 810 |
SLEEP APNOEA SYNDROME |
30 |
0.0016 |
| 811 |
CARDIAC FAILURE CONGESTIVE |
125 |
0.0016 |
| 812 |
ORTHOSTATIC HYPOTENSION |
27 |
0.0015 |
| 813 |
UNRESPONSIVE TO STIMULI |
40 |
0.0015 |
| 814 |
EOSINOPHILIA |
27 |
0.0015 |
| 815 |
EAR INFECTION |
41 |
0.0015 |
| 816 |
RASH PAPULAR |
34 |
0.0015 |
| 817 |
PRODUCT PRESCRIBING ISSUE |
33 |
0.0015 |
| 818 |
VENTRICULAR TACHYCARDIA |
25 |
0.0015 |
| 819 |
LACTIC ACIDOSIS |
49 |
0.0015 |
| 820 |
ABDOMINAL PAIN |
351 |
0.0015 |
| 821 |
PERITONITIS |
31 |
0.0015 |
| 822 |
BLOOD TRIGLYCERIDES INCREASED |
26 |
0.0015 |
| 823 |
PULMONARY FIBROSIS |
28 |
0.0015 |
| 824 |
DRUG LEVEL INCREASED |
24 |
0.0014 |
| 825 |
URINARY TRACT INFECTION |
247 |
0.0014 |
| 826 |
RASH ERYTHEMATOUS |
69 |
0.0014 |
| 827 |
ANAPHYLACTIC SHOCK |
37 |
0.0014 |
| 828 |
DYSPNOEA EXERTIONAL |
54 |
0.0014 |
| 829 |
PALLOR |
39 |
0.0014 |
| 830 |
DERMATITIS |
30 |
0.0014 |
| 831 |
AGITATION |
105 |
0.0014 |
| 832 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
101 |
0.0014 |
| 833 |
CONDITION AGGRAVATED |
431 |
0.0014 |
| 834 |
DRUG EFFECT INCOMPLETE |
51 |
0.0014 |
| 835 |
EPISTAXIS |
105 |
0.0014 |
| 836 |
ELECTROCARDIOGRAM QT PROLONGED |
50 |
0.0014 |
| 837 |
DYSARTHRIA |
52 |
0.0014 |
| 838 |
URINARY RETENTION |
46 |
0.0014 |
| 839 |
APATHY |
20 |
0.0014 |
| 840 |
DEATH |
1176 |
0.0014 |
| 841 |
ACUTE MYOCARDIAL INFARCTION |
40 |
0.0014 |
| 842 |
CHRONIC KIDNEY DISEASE |
102 |
0.0013 |
| 843 |
ORAL PAIN |
30 |
0.0013 |
| 844 |
OSTEOMYELITIS |
24 |
0.0013 |
| 845 |
LETHARGY |
76 |
0.0013 |
| 846 |
DRUG INTERACTION |
209 |
0.0013 |
| 847 |
CARDIAC DISORDER |
121 |
0.0013 |
| 848 |
MENINGIOMA |
20 |
0.0013 |
| 849 |
COUGH |
359 |
0.0013 |
| 850 |
GASTROENTERITIS VIRAL |
23 |
0.0013 |
| 851 |
HAEMATOMA |
33 |
0.0013 |
| 852 |
NEOPLASM MALIGNANT |
84 |
0.0013 |
| 853 |
PANCREATITIS |
66 |
0.0012 |
| 854 |
CATARACT |
74 |
0.0012 |
| 855 |
ILL-DEFINED DISORDER |
74 |
0.0012 |
| 856 |
TREMOR |
201 |
0.0012 |
| 857 |
VOMITING |
569 |
0.0012 |
| 858 |
ARRHYTHMIA |
56 |
0.0012 |
| 859 |
PHOTOPHOBIA |
22 |
0.0012 |
| 860 |
INFLUENZA |
129 |
0.0012 |
| 861 |
DECREASED APPETITE |
266 |
0.0011 |
| 862 |
HAEMATEMESIS |
29 |
0.0011 |
| 863 |
VISUAL ACUITY REDUCED |
38 |
0.0011 |
| 864 |
RASH |
498 |
0.0011 |
| 865 |
SKIN DISORDER |
38 |
0.0011 |
| 866 |
FLUID RETENTION |
57 |
0.0011 |
| 867 |
ANAPHYLACTIC REACTION |
61 |
0.0011 |
| 868 |
RESPIRATORY ARREST |
30 |
0.0011 |
| 869 |
NAUSEA |
849 |
0.0011 |
| 870 |
OSTEOPOROSIS |
44 |
0.0011 |
| 871 |
LOSS OF CONSCIOUSNESS |
136 |
0.0011 |
| 872 |
PRODUCT ADMINISTRATION ERROR |
21 |
0.0010 |
| 873 |
HALLUCINATION |
76 |
0.0010 |
| 874 |
DYSPNOEA |
569 |
0.0010 |
| 875 |
RASH GENERALISED |
26 |
0.0010 |
| 876 |
NEURALGIA |
24 |
0.0010 |
| 877 |
POLLAKIURIA |
41 |
0.0010 |
| 878 |
LABORATORY TEST ABNORMAL |
29 |
0.0010 |
| 879 |
RECTAL HAEMORRHAGE |
42 |
0.0010 |
| 880 |
BONE PAIN |
57 |
0.0010 |
| 881 |
ASTHENIA |
365 |
0.0010 |
| 882 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
21 |
0.0010 |
| 883 |
WEIGHT DECREASED |
270 |
0.0010 |
| 884 |
SKIN ULCER |
25 |
0.0010 |
| 885 |
SKIN EXFOLIATION |
80 |
0.0009 |
| 886 |
CHEST DISCOMFORT |
96 |
0.0009 |
| 887 |
DEHYDRATION |
124 |
0.0009 |
| 888 |
MYALGIA |
158 |
0.0009 |
| 889 |
DYSPHAGIA |
88 |
0.0009 |
| 890 |
HAEMATOCHEZIA |
51 |
0.0009 |
| 891 |
BLISTER |
51 |
0.0009 |
| 892 |
SOMNOLENCE |
178 |
0.0009 |
| 893 |
URINARY INCONTINENCE |
26 |
0.0009 |
| 894 |
DISTURBANCE IN ATTENTION |
47 |
0.0009 |
| 895 |
SYNCOPE |
86 |
0.0009 |
| 896 |
RHINORRHOEA |
55 |
0.0009 |
| 897 |
OSTEONECROSIS OF JAW |
21 |
0.0008 |
| 898 |
SPEECH DISORDER |
44 |
0.0008 |
| 899 |
RHABDOMYOLYSIS |
35 |
0.0008 |
| 900 |
DIVERTICULITIS |
23 |
0.0008 |
| 901 |
MENTAL DISORDER |
36 |
0.0008 |
| 902 |
DIABETES MELLITUS |
63 |
0.0008 |
| 903 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
21 |
0.0008 |
| 904 |
MOVEMENT DISORDER |
26 |
0.0008 |
| 905 |
ABDOMINAL DISTENSION |
83 |
0.0008 |
| 906 |
BRONCHITIS |
58 |
0.0008 |
| 907 |
HYPERSENSITIVITY |
143 |
0.0008 |
| 908 |
RENAL INJURY |
22 |
0.0007 |
| 909 |
DYSKINESIA |
29 |
0.0007 |
| 910 |
ECZEMA |
37 |
0.0007 |
| 911 |
VISUAL IMPAIRMENT |
87 |
0.0007 |
| 912 |
CHEST PAIN |
130 |
0.0007 |
| 913 |
CHOLELITHIASIS |
23 |
0.0007 |
| 914 |
RASH PRURITIC |
38 |
0.0007 |
| 915 |
IMPAIRED HEALING |
23 |
0.0007 |
| 916 |
HEADACHE |
439 |
0.0007 |
| 917 |
PARAESTHESIA |
110 |
0.0007 |
| 918 |
FATIGUE |
541 |
0.0007 |
| 919 |
TRANSIENT ISCHAEMIC ATTACK |
23 |
0.0007 |
| 920 |
PSYCHOTIC DISORDER |
20 |
0.0007 |
| 921 |
HEART RATE INCREASED |
67 |
0.0007 |
| 922 |
ERYTHEMA |
139 |
0.0007 |
| 923 |
MALAISE |
282 |
0.0006 |
| 924 |
PROSTATE CANCER |
51 |
0.0006 |
| 925 |
ARTHROPATHY |
35 |
0.0006 |
| 926 |
ABDOMINAL PAIN UPPER |
126 |
0.0006 |
| 927 |
BACK PAIN |
141 |
0.0006 |
| 928 |
WEIGHT INCREASED |
130 |
0.0006 |
| 929 |
RESTLESSNESS |
21 |
0.0006 |
| 930 |
HYPOAESTHESIA |
85 |
0.0006 |
| 931 |
BALANCE DISORDER |
49 |
0.0006 |
| 932 |
INTESTINAL OBSTRUCTION |
21 |
0.0006 |
| 933 |
VISION BLURRED |
76 |
0.0006 |
| 934 |
OROPHARYNGEAL PAIN |
50 |
0.0005 |
| 935 |
SWELLING FACE |
35 |
0.0005 |
| 936 |
COLITIS ULCERATIVE |
24 |
0.0005 |
| 937 |
NECK PAIN |
30 |
0.0005 |
| 938 |
CEREBROVASCULAR ACCIDENT |
88 |
0.0005 |
| 939 |
VERTIGO |
31 |
0.0005 |
| 940 |
CONSTIPATION |
108 |
0.0005 |
| 941 |
WHEEZING |
29 |
0.0005 |
| 942 |
SWELLING |
45 |
0.0005 |
| 943 |
DRY MOUTH |
39 |
0.0005 |
| 944 |
EYE PAIN |
27 |
0.0005 |
| 945 |
MEMORY IMPAIRMENT |
64 |
0.0005 |
| 946 |
HYPERHIDROSIS |
60 |
0.0005 |
| 947 |
ARTHRALGIA |
193 |
0.0005 |
| 948 |
NASAL CONGESTION |
27 |
0.0005 |
| 949 |
DYSPEPSIA |
44 |
0.0004 |
| 950 |
AMNESIA |
29 |
0.0004 |
| 951 |
DYSGEUSIA |
31 |
0.0004 |
| 952 |
UNEVALUABLE EVENT |
31 |
0.0004 |
| 953 |
DRY EYE |
20 |
0.0004 |
| 954 |
MEDICATION ERROR |
22 |
0.0004 |
| 955 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
20 |
0.0004 |
| 956 |
ARTHRITIS |
29 |
0.0004 |
| 957 |
ALOPECIA |
72 |
0.0004 |
| 958 |
PAIN |
224 |
0.0004 |
| 959 |
PRURITUS |
138 |
0.0004 |
| 960 |
GAIT DISTURBANCE |
68 |
0.0004 |
| 961 |
FALL |
118 |
0.0004 |
| 962 |
INTENTIONAL PRODUCT MISUSE |
31 |
0.0004 |
| 963 |
CONTUSION |
34 |
0.0004 |
| 964 |
EYE IRRITATION |
20 |
0.0003 |
| 965 |
ADVERSE EVENT |
32 |
0.0003 |
| 966 |
DIZZINESS |
172 |
0.0003 |
| 967 |
INSOMNIA |
87 |
0.0003 |
| 968 |
PALPITATIONS |
38 |
0.0003 |
| 969 |
PAIN IN EXTREMITY |
95 |
0.0003 |
| 970 |
NO ADVERSE EVENT |
58 |
0.0003 |
| 971 |
URTICARIA |
51 |
0.0003 |
| 972 |
DEPRESSION |
67 |
0.0003 |
| 973 |
FLUSHING |
29 |
0.0003 |
| 974 |
BLOOD PRESSURE INCREASED |
42 |
0.0003 |
| 975 |
INFLUENZA LIKE ILLNESS |
21 |
0.0003 |
| 976 |
MATERNAL EXPOSURE DURING PREGNANCY |
22 |
0.0002 |
| 977 |
PERIPHERAL SWELLING |
38 |
0.0002 |
| 978 |
MYOCARDIAL INFARCTION |
42 |
0.0002 |
| 979 |
SUICIDAL IDEATION |
22 |
0.0002 |
| 980 |
MUSCLE SPASMS |
44 |
0.0002 |
| 981 |
MUSCULOSKELETAL STIFFNESS |
21 |
0.0002 |
| 982 |
BREAST CANCER |
21 |
0.0002 |
| 983 |
ABDOMINAL DISCOMFORT |
36 |
0.0002 |
| 984 |
DRY SKIN |
25 |
0.0002 |
| 985 |
ANXIETY |
51 |
0.0002 |
| 986 |
BLOOD GLUCOSE INCREASED |
29 |
0.0002 |
| 987 |
NASOPHARYNGITIS |
24 |
0.0001 |
| 988 |
OVERDOSE |
27 |
0.0001 |
| 989 |
FEELING ABNORMAL |
22 |
0.0001 |